Poniard Pharma (PARD) Posts Q3 Loss of $0.29, In-Line with Estimates
Tweet Send to a Friend
Poniard Pharmaceuticals (NASDAQ: PARD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
